Xonvea

Medicinal product

(Invented) name

Xonvea

Active substance (s)

Doksilamino-vandenilio sukcinatas/Piridoksino hidrochloridas

Strength

10 mg/10 mg

Pharmaceutical form

skrandyje neirios tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R06AA59, Doxylamine, combinations

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-08-27

Date of renewal

Documents

2809_Xonvea 10 mg10 mg skran neir tabl_PZ_2025-08-27.docx

2809_Xonvea 10 mg10 mg skran neir tabl_PL_2025-08-27.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Doksilamino-vandenilio sukcinatas	10 mg
Piridoksino hidrochloridas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118451	104557	1104557	lizdinė plokštelė	N20		Receptinis	LT/L/25/2809/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-08-27	Registruotas